LEUKEMIA RESEARCH

随着编辑委员会的修订，白血病研究正在进一步发展其目标，即为所有参与白血病和其他血液恶性肿瘤的基础研究和应用临床研究的卫生保健专业人员提供全面和最新的信息。编辑鼓励提交有关正常和白血病造血、生物化学、细胞生物学、免疫学、分子生物学以及流行病学和临床研究的文章。特别地，主要的兴趣将是文章，包括应用癌基因，生长因子，细胞标记物，细胞周期和分化剂，新疗法和临床试验在急性和慢性白血病以及骨髓增生异常综合征。此外，我们还征集了一些关于大范围肿瘤患者在接受高剂量治疗并尝试治疗后骨髓或干细胞重建迅速增加的特点的文章。更多信息请联系骨髓增生异常综合征基金会http://www.mds-found.org/

With a revised editorial board in place, Leukemia Research is further developing its goal of bringing comprehensive and current information to all health care professionals involved in basic research and applied clinical research in both leukemias and other hematologic malignancies. The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology, molecular biology as well as epidemiologic and clinical studies. Specifically, of major interest will be articles that encompass the application of oncogenes, growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition we solicit selected articles on the rapidly increasing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients with a wide range of neoplasms.For more information contact the Myelodysplastic Syndromes Foundation at http://www.mds-foundation.org/